The global image-guided therapy systems market size reached USD 5.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.3 Billion by 2033, exhibiting a growth rate (CAGR) of 4.97% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 5.8 Billion |
Market Forecast in 2033
|
USD 9.3 Billion |
Market Growth Rate 2025-2033 | 4.97% |
Image-guided therapy (IGT) systems are used to plan, perform, and evaluate surgical procedures and therapeutic interventions. They assist healthcare professionals in providing real-time treatment, which leads to shorter hospital stays and fewer repeated procedures. They also offer integrated solutions for advanced minimally invasive surgeries (MIS). Some of the commonly utilized modalities of IGT systems include magnetic resonance imaging (MRI) and computed tomography (CT). These modalities are supported by ultrasound, angiography, tracking tools, integrated software, and surgical navigation equipment for better patient outcomes.
The rising number of individuals diagnosed with different types of cancer represents one of the prime factors propelling the global IGT systems market growth. Additionally, the increasing adoption of modern clinical procedures and smart medical devices to get relevant information at the point of care (POC), along with the escalating demand for MI therapies, are contributing to the market growth. Presently, the leading players are also introducing different procedures for IGT systems that utilize imaging and special instruments to treat internal organs and tissues without a surgical incision. These systems help improve patient outcomes, reduce the burden on the healthcare system, and advance precision medical care, which is catalyzing the demand for IGT systems worldwide. The growing geriatric population and corresponding age-related chronic diseases are further strengthening the market growth. Apart from this, expanding collaboration between healthcare firms is anticipated to enhance the effectiveness of treatment therapies and influence the market positively.
IMARC Group provides an analysis of the key trends in each sub-segment of the global image-guided therapy systems market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on product, application and end use.
Breakup by Product:
Breakup by Application:
Breakup by End Use:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Analogic Corporation, Brainlab AG, FUJIFILM Holdings Corporation, General Electric Company, Karl Storz SE & Co. KG, Koninklijke Philips N.V., Medtronic plc, Siemens Healthineers AG, Stryker Corporation and Varian Medical Systems Inc.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Product, Application, End Use, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Analogic Corporation, Brainlab AG, FUJIFILM Holdings Corporation, General Electric Company, Karl Storz SE & Co. KG, Koninklijke Philips N.V., Medtronic plc, Siemens Healthineers AG, Stryker Corporation and Varian Medical Systems Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report: